Peter Salzmann - Director at Corbus Pharmaceuticals Holdings, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock, par value $0.0001 per share	2.78K	$83.5K	$30.00	May 30, 2024	Direct
Stock Option (right to buy)	2.78K	$13.8K	$4.97	May 16, 2024	Direct	Common Stock

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.